EPO and obesity due to melanocortin 4 receptor deficiency: Literature reports relating EPO to obesity, however, are mainly focused on exogenous EPO administration, which reduces fat accumulation and improves glycaemic characteristics [30], and little information is available about endogenous EPO in obesity.